BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38115553)

  • 1. Poor prognosis of young male patients with stage III colorectal cancer: A multicenter retrospective study.
    Okamoto K; Sasaki K; Nozawa H; Murono K; Emoto S; Yamauchi S; Sugihara K; Ishihara S
    J Surg Oncol; 2024 Mar; 129(4):785-792. PubMed ID: 38115553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-world Data for High-risk Stage II Colorectal Cancer - The Role of Tumor Side in the Adjuvant Setting.
    Araujo CS; Venchiarutti Moniz CM; Bonadio RC; Watarai GY; Rojas J; Nogueira PVS; Martinez JK; Moraes PMG; Braghiroli MI; Sabbaga J; Hoff PM
    Clin Colorectal Cancer; 2021 Jun; 20(2):e100-e108. PubMed ID: 33234431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal obstruction is a potential prognostic factor for stage II colorectal cancer.
    Okuda Y; Shimura T; Yamada T; Hirata Y; Yamaguchi R; Sakamoto E; Kataoka H
    Int J Clin Oncol; 2018 Dec; 23(6):1101-1111. PubMed ID: 29948240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced-Stage Colorectal Cancer in Persons Younger Than 50 Years Not Associated With Longer Duration of Symptoms or Time to Diagnosis.
    Chen FW; Sundaram V; Chew TA; Ladabaum U
    Clin Gastroenterol Hepatol; 2017 May; 15(5):728-737.e3. PubMed ID: 27856366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Young-age onset colorectal cancer in Brazil: Analysis of incidence, clinical features, and outcomes in a tertiary cancer center.
    Silva ACB; Vicentini MFB; Mendoza EZ; Fujiki FK; da Fonseca LG; Braghiroli MIFM; Hoff PM
    Curr Probl Cancer; 2019 Oct; 43(5):477-486. PubMed ID: 30826126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical impact of primary tumor sidedness and sex on unresectable post-recurrence survival in resected pathological stage II-III colorectal cancers: a nationwide multicenter retrospective study.
    Abe S; Kawai K; Nozawa H; Sasaki K; Murono K; Emoto S; Ozawa T; Yokoyama Y; Nagai Y; Anzai H; Sonoda H; Yamauchi S; Sugihara K; Ishihara S
    BMC Cancer; 2022 May; 22(1):486. PubMed ID: 35501727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor Prognosis in Patients With Stage III Colorectal Cancer Receiving Adjuvant FOLFOX/CAPOX Therapy Is Predicted by the Presence of Many Poorly Differentiated Clusters.
    Yoshimatsu K; Kono T; Satake M; Ito Y; Shiozawa S; Tanaka H; Higashida M; Okada T; Endo S; Fujiwara Y; Ueno T
    Anticancer Res; 2023 Jul; 43(7):3235-3240. PubMed ID: 37352004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological patterns and survival outcomes of colorectal cancer among young adults in Malaysia: an institutional cohort study.
    Wong SW; Ling DY; Yeow RQ; Chong RW; Aziz MRA; Aziz NA; Poh KS; Roslani AC
    Singapore Med J; 2021 Dec; 62(12):636-641. PubMed ID: 34005846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GALNT14 Genotype Predicts Postoperative Outcome of Stage III Colorectal Cancer With Oxaliplatin as Adjuvant Chemotherapy.
    Lin WR; Chiang JM; Liang KH; Lim SN; Lai MW; Tsou YK; Hsieh TY; Hsu CK; Yeh CT
    Medicine (Baltimore); 2016 Apr; 95(17):e3487. PubMed ID: 27124048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of primary tumor sidedness on survival in early-onset colorectal cancer by stage: A National Veterans Affairs retrospective analysis.
    Azar I; Al Masalmeh N; Esfandiarifard S; Virk G; Kiwan W; Frank Shields A; Mehdi S; Philip PA
    Cancer Med; 2021 May; 10(9):2987-2995. PubMed ID: 33797856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sidedness Matters: Surrogate Biomarkers Prognosticate Colorectal Cancer upon Anatomic Location.
    Ben-Aharon I; Goshen-Lago T; Sternschuss M; Morgenstern S; Geva R; Beny A; Dror Y; Steiner M; Hubert A; Idelevich E; Shulman K; Mishaeli M; Man S; Liebermann N; Soussan-Gutman L; Brenner B
    Oncologist; 2019 Aug; 24(8):e696-e701. PubMed ID: 30755502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated tumor-to-liver uptake ratio (TLR) from
    Huang J; Huang L; Zhou J; Duan Y; Zhang Z; Wang X; Huang P; Tan S; Hu P; Wang J; Huang M
    Eur J Nucl Med Mol Imaging; 2017 Nov; 44(12):1958-1968. PubMed ID: 28812134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Outcome and Prognostic Factors of Sporadic Colorectal Cancer in Young Patients: A Large Institutional-Based Retrospective Study.
    Kim TJ; Kim ER; Hong SN; Chang DK; Kim YH
    Medicine (Baltimore); 2016 May; 95(19):e3641. PubMed ID: 27175682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-Onset Colorectal Adenocarcinoma in the IDEA Database: Treatment Adherence, Toxicities, and Outcomes With 3 and 6 Months of Adjuvant Fluoropyrimidine and Oxaliplatin.
    Fontana E; Meyers J; Sobrero A; Iveson T; Shields AF; Taieb J; Yoshino T; Souglakos I; Smyth EC; Lordick F; Moehler M; Giraut A; Harkin A; Labianca R; Meyerhardt J; André T; Boukovinas I; Lonardi S; Saunders M; Vernerey D; Oki E; Georgoulias V; Ben-Aharon I; Shi Q
    J Clin Oncol; 2021 Dec; 39(36):4009-4019. PubMed ID: 34752136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A relationship to survival is seen by combining the factors of mismatch repair status, tumor location and age of onset in colorectal cancer patients.
    Li P; Xiao Z; Braciak TA; Ou Q; Chen G; Oduncu FS
    PLoS One; 2017; 12(3):e0172799. PubMed ID: 28253296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of chemotherapy-associated neutrophil/ lymphocyte counts on prognosis of adjuvant chemotherapy in colorectal cancer.
    Chu-Yuan H; Jing P; Yi-Sheng W; He-Ping P; Hui Y; Chu-Xiong Z; Guo-Jian L; Guo-Qiang W
    BMC Cancer; 2013 Apr; 13():177. PubMed ID: 23551939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and comorbidity on prognosis and application of adjuvant chemotherapy in elderly Japanese patients with colorectal cancer: A retrospective multicentre study.
    Yamano T; Yamauchi S; Kimura K; Babaya A; Hamanaka M; Kobayashi M; Fukumoto M; Tsukamoto K; Noda M; Tomita N; Sugihara K;
    Eur J Cancer; 2017 Aug; 81():90-101. PubMed ID: 28622612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a 55-gene classifier as a prognostic biomarker for adjuvant chemotherapy in stage III colon cancer patients.
    Oki E; Shinto E; Shimokawa M; Yamaguchi S; Ishiguro M; Hasegawa S; Takii Y; Ishida H; Kusumoto T; Morita M; Tomita N; Shiozawa M; Tanaka M; Ozawa H; Hashiguchi Y; Ohnuma S; Tada S; Matsushima T; Hase K
    BMC Cancer; 2021 Dec; 21(1):1332. PubMed ID: 34906120
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis.
    Li Y; Feng Y; Dai W; Li Q; Cai S; Peng J
    Clin Colorectal Cancer; 2019 Mar; 18(1):e104-e116. PubMed ID: 30448100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.